Ex­clu­sive: NTx rais­es $47.5M Se­ries B to com­mer­cial­ize pro­tein, mR­NA man­u­fac­tur­ing plat­forms 

Ear­ly-stage bio­man­u­fac­tur­er Na­ture’s Tool­box (NTx) has col­lect­ed $47.5 mil­lion in a Se­ries B raise to bring its mR­NA and pro­tein pro­duc­tion plat­forms to mar­ket, as well as to dou­ble its head­count and ex­pand its Rio Ran­cho, NM fa­cil­i­ty.

NTx has two dif­fer­ent man­u­fac­tur­ing plat­forms: one called NTxscribe, which pro­duces mR­NA, and the oth­er is named NTx­press, which is de­signed to make pro­teins.

The Se­ries B is in­tend­ed to bring NTxscribe to mar­ket in the third quar­ter of 2024, with a pro­to­type avail­able in the first half of next year, CEO Jamie Cof­fin told End­points News in an in­ter­view. Mean­while, the pro­tein plat­form is in ear­li­er stages of de­vel­op­ment, he not­ed.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.